Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose dependent manner: Implications for inotropy.

Efentakis P, Varela A, Chavdoula E, Sigala F, Sanoudou D, Tenta R, Gioti K, Kostomitsopoulos N, Papapetropoulos A, Tasouli A, Farmakis D, Davos CH, Klinakis A, Suter T, Cokkinos DV, Iliodromitis EK, Wenzel P, Andreadou I.

Cardiovasc Res. 2019 Jun 22. pii: cvz163. doi: 10.1093/cvr/cvz163. [Epub ahead of print]

PMID:
31228183
2.

Association study of the CTH 1364 G>T polymorphism with coronary artery disease in the Greek population.

Giannakopoulou E, Konstantinou F, Ragia G, Gerontitis Z, Tavridou A, Papapetropoulos A, Mikroulis D, Manolopoulos VG.

Drug Metab Pers Ther. 2019 Mar 12;34(1). pii: /j/dmdi.2019.34.issue-1/dmpt-2018-0033/dmpt-2018-0033.xml. doi: 10.1515/dmpt-2018-0033.

PMID:
30860977
3.

Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.

Nikolaou PE, Boengler K, Efentakis P, Vouvogiannopoulou K, Zoga A, Gaboriaud-Kolar N, Myrianthopoulos V, Alexakos P, Kostomitsopoulos N, Rerras I, Tsantili-Kakoulidou A, Skaltsounis AL, Papapetropoulos A, Iliodromitis EK, Schulz R, Andreadou I.

Cardiovasc Res. 2019 Jun 1;115(7):1228-1243. doi: 10.1093/cvr/cvz061.

PMID:
30843027
4.

3-Mercaptopyruvate sulfurtransferase supports endothelial cell angiogenesis and bioenergetics.

Abdollahi Govar A, Törő G, Szaniszlo P, Pavlidou A, Bibli SI, Thanki K, Resto VA, Chao C, Hellmich MR, Szabo C, Papapetropoulos A, Módis K.

Br J Pharmacol. 2019 Jan 14. doi: 10.1111/bph.14574. [Epub ahead of print]

PMID:
30644090
5.

Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug.

Bibli SI, Papapetropoulos A, Iliodromitis EK, Daiber A, Randriamboavonjy V, Steven S, Brouckaert P, Chatzianastasiou A, Kypreos KE, Hausenloy DJ, Fleming I, Andreadou I.

Cardiovasc Res. 2019 Mar 1;115(3):625-636. doi: 10.1093/cvr/cvy222.

PMID:
30165375
6.

Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice.

Glynos C, Bibli SI, Katsaounou P, Pavlidou A, Magkou C, Karavana V, Topouzis S, Kalomenidis I, Zakynthinos S, Papapetropoulos A.

Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L662-L672. doi: 10.1152/ajplung.00389.2017. Epub 2018 Aug 9.

PMID:
30091379
7.

A selective and sensitive method for quantification of endogenous polysulfide production in biological samples.

Bibli SI, Luck B, Zukunft S, Wittig J, Chen W, Xian M, Papapetropoulos A, Hu J, Fleming I.

Redox Biol. 2018 Sep;18:295-304. doi: 10.1016/j.redox.2018.07.016. Epub 2018 Jul 21.

8.

Cystathionine γ Lyase Sulfhydrates the RNA Binding Protein Human Antigen R to Preserve Endothelial Cell Function and Delay Atherogenesis.

Bibli SI, Hu J, Sigala F, Wittig I, Heidler J, Zukunft S, Tsilimigras DI, Randriamboavonjy V, Wittig J, Kojonazarov B, Schürmann C, Siragusa M, Siuda D, Luck B, Abdel Malik R, Filis KA, Zografos G, Chen C, Wang DW, Pfeilschifter J, Brandes RP, Szabo C, Papapetropoulos A, Fleming I.

Circulation. 2019 Jan 2;139(1):101-114. doi: 10.1161/CIRCULATIONAHA.118.034757.

PMID:
29970364
9.

Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity.

Mitidieri E, Tramontano T, Gurgone D, Citi V, Calderone V, Brancaleone V, Katsouda A, Nagahara N, Papapetropoulos A, Cirino G, d'Emmanuele di Villa Bianca R, Sorrentino R.

Nitric Oxide. 2018 May 1;75:53-59. doi: 10.1016/j.niox.2018.02.003. Epub 2018 Feb 13.

PMID:
29452248
10.

Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells.

Szczesny B, Marcatti M, Ahmad A, Montalbano M, Brunyánszki A, Bibli SI, Papapetropoulos A, Szabo C.

Sci Rep. 2018 Jan 17;8(1):914. doi: 10.1038/s41598-018-19216-1.

11.

Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2).

Ha J, Xu Y, Kawano T, Hendon T, Baki L, Garai S, Papapetropoulos A, Thakur GA, Plant LD, Logothetis DE.

J Biol Chem. 2018 Mar 9;293(10):3546-3561. doi: 10.1074/jbc.RA117.001679. Epub 2018 Jan 9.

12.

Inventing new therapies without reinventing the wheel: the power of drug repurposing.

Papapetropoulos A, Szabo C.

Br J Pharmacol. 2018 Jan;175(2):165-167. doi: 10.1111/bph.14081.

13.

Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation.

Giannakopoulou E, Konstantinou F, Ragia G, Tavridou A, Karaglani M, Chatzaki E, Papapetropoulos A, Mikroulis D, Manolopoulos VG.

OMICS. 2017 Dec;21(12):741-748. doi: 10.1089/omi.2017.0149. Epub 2017 Nov 27.

PMID:
29173085
14.

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2018 Apr;14:694-696. doi: 10.1016/j.redox.2017.10.001. Epub 2017 Oct 26. No abstract available.

15.

Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells.

Untereiner AA, Pavlidou A, Druzhyna N, Papapetropoulos A, Hellmich MR, Szabo C.

Biochem Pharmacol. 2018 Mar;149:174-185. doi: 10.1016/j.bcp.2017.10.007. Epub 2017 Oct 20.

16.

Hydrogen Sulfide Preserves Endothelial Nitric Oxide Synthase Function by Inhibiting Proline-Rich Kinase 2: Implications for Cardiomyocyte Survival and Cardioprotection.

Bibli SI, Szabo C, Chatzianastasiou A, Luck B, Zukunft S, Fleming I, Papapetropoulos A.

Mol Pharmacol. 2017 Dec;92(6):718-730. doi: 10.1124/mol.117.109645. Epub 2017 Oct 13.

PMID:
29030392
17.

Reduced adipose tissue H2S in obesity.

Katsouda A, Szabo C, Papapetropoulos A.

Pharmacol Res. 2018 Feb;128:190-199. doi: 10.1016/j.phrs.2017.09.023. Epub 2017 Oct 2.

PMID:
28982640
18.
19.

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2017 Oct;13:94-162. doi: 10.1016/j.redox.2017.05.007. Epub 2017 May 18. Review. Erratum in: Redox Biol. 2018 Apr;14 :694-696.

20.

Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2.

Bibli SI, Zhou Z, Zukunft S, Fisslthaler B, Andreadou I, Szabo C, Brouckaert P, Fleming I, Papapetropoulos A.

Cardiovasc Res. 2017 Jul 1;113(8):926-937. doi: 10.1093/cvr/cvx058.

PMID:
28444132
21.

Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin.

Sigala F, Efentakis P, Karageorgiadi D, Filis K, Zampas P, Iliodromitis EK, Zografos G, Papapetropoulos A, Andreadou I.

Redox Biol. 2017 Aug;12:70-81. doi: 10.1016/j.redox.2017.02.006. Epub 2017 Feb 12.

22.

Vascular biology of hydrogen sulfide.

Kanagy NL, Szabo C, Papapetropoulos A.

Am J Physiol Cell Physiol. 2017 May 1;312(5):C537-C549. doi: 10.1152/ajpcell.00329.2016. Epub 2017 Feb 1. Review.

23.

Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning.

Bibli SI, Andreadou I, Glynos C, Chatzianastasiou A, Toumpanakis D, Zakynthinos S, Vasilakopoulos T, Iliodromitis EK, Papapetropoulos A.

Am J Physiol Heart Circ Physiol. 2016 Nov 1;311(5):H1321-H1332. doi: 10.1152/ajpheart.00925.2015. Epub 2016 Sep 30.

24.

Regulation and role of endogenously produced hydrogen sulfide in angiogenesis.

Katsouda A, Bibli SI, Pyriochou A, Szabo C, Papapetropoulos A.

Pharmacol Res. 2016 Nov;113(Pt A):175-185. doi: 10.1016/j.phrs.2016.08.026. Epub 2016 Aug 26. Review.

25.

Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Druzhyna N, Szczesny B, Olah G, Módis K, Asimakopoulou A, Pavlidou A, Szoleczky P, Gerö D, Yanagi K, Törö G, López-García I, Myrianthopoulos V, Mikros E, Zatarain JR, Chao C, Papapetropoulos A, Hellmich MR, Szabo C.

Pharmacol Res. 2016 Nov;113(Pt A):18-37. doi: 10.1016/j.phrs.2016.08.016. Epub 2016 Aug 10.

26.

(1)H, (13)C, (15)N backbone and side-chain resonance assignment of Nostoc sp. C139A variant of the heme-nitric oxide/oxygen binding (H-NOX) domain.

Alexandropoulos II, Argyriou AI, Marousis KD, Topouzis S, Papapetropoulos A, Spyroulias GA.

Biomol NMR Assign. 2016 Oct;10(2):395-400. doi: 10.1007/s12104-016-9707-6. Epub 2016 Sep 10.

PMID:
27614467
27.

Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.

Zhou Z, Martin E, Sharina I, Esposito I, Szabo C, Bucci M, Cirino G, Papapetropoulos A.

Pharmacol Res. 2016 Sep;111:556-562. doi: 10.1016/j.phrs.2016.06.029. Epub 2016 Jul 1.

28.

Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.

Chatzianastasiou A, Bibli SI, Andreadou I, Efentakis P, Kaludercic N, Wood ME, Whiteman M, Di Lisa F, Daiber A, Manolopoulos VG, Szabó C, Papapetropoulos A.

J Pharmacol Exp Ther. 2016 Sep;358(3):431-40. doi: 10.1124/jpet.116.235119. Epub 2016 Jun 24.

29.

D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase.

Brancaleone V, Esposito I, Gargiulo A, Vellecco V, Asimakopoulou A, Citi V, Calderone V, Gobbetti T, Perretti M, Papapetropoulos A, Bucci M, Cirino G.

Br J Pharmacol. 2016 May;173(9):1556-65. doi: 10.1111/bph.13459. Epub 2016 Mar 23.

30.

Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents.

Lougiakis N, Papapetropoulos A, Gikas E, Toumpas S, Efentakis P, Wedmann R, Zoga A, Zhou Z, Iliodromitis EK, Skaltsounis AL, Filipovic MR, Pouli N, Marakos P, Andreadou I.

J Med Chem. 2016 Mar 10;59(5):1776-90. doi: 10.1021/acs.jmedchem.5b01223. Epub 2016 Feb 8.

PMID:
26809888
31.

Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes.

Andreadou I, Iliodromitis EK, Szabo C, Papapetropoulos A.

Basic Res Cardiol. 2015 Sep;110(5):510. doi: 10.1007/s00395-015-0510-9. Epub 2015 Aug 30.

32.

Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors.

Whiteman M, Perry A, Zhou Z, Bucci M, Papapetropoulos A, Cirino G, Wood ME.

Handb Exp Pharmacol. 2015;230:337-63. doi: 10.1007/978-3-319-18144-8_17. Review.

PMID:
26162843
33.

The role of H2S bioavailability in endothelial dysfunction.

Wang R, Szabo C, Ichinose F, Ahmed A, Whiteman M, Papapetropoulos A.

Trends Pharmacol Sci. 2015 Sep;36(9):568-78. doi: 10.1016/j.tips.2015.05.007. Epub 2015 Jun 9. Review.

34.

ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.

Umaru B, Pyriochou A, Kotsikoris V, Papapetropoulos A, Topouzis S.

J Pharmacol Exp Ther. 2015 Jul;354(1):79-87. doi: 10.1124/jpet.114.222000. Epub 2015 May 14.

PMID:
25977483
35.

Pharmacology of the 'gasotransmitters' NO, CO and H2S: translational opportunities.

Papapetropoulos A, Foresti R, Ferdinandy P.

Br J Pharmacol. 2015 Mar;172(6):1395-6. doi: 10.1111/bph.13005. No abstract available.

36.

Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.

Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A.

Cardiovasc Res. 2015 Jun 1;106(3):432-42. doi: 10.1093/cvr/cvv129. Epub 2015 Apr 13.

37.

Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid.

Coletta C, Módis K, Szczesny B, Brunyánszki A, Oláh G, Rios EC, Yanagi K, Ahmad A, Papapetropoulos A, Szabo C.

Mol Med. 2015 Feb 18;21:1-14. doi: 10.2119/molmed.2015.00035.

38.

Role of cGMP in hydrogen sulfide signaling.

Bibli SI, Yang G, Zhou Z, Wang R, Topouzis S, Papapetropoulos A.

Nitric Oxide. 2015 Apr 30;46:7-13. doi: 10.1016/j.niox.2014.12.004. Epub 2014 Dec 29. Review.

PMID:
25553675
39.

Guanylyl cyclase activation reverses resistive breathing-induced lung injury and inflammation.

Glynos C, Toumpanakis D, Loverdos K, Karavana V, Zhou Z, Magkou C, Dettoraki M, Perlikos F, Pavlidou A, Kotsikoris V, Topouzis S, Theocharis SE, Brouckaert P, Giannis A, Papapetropoulos A, Vassilakopoulos T.

Am J Respir Cell Mol Biol. 2015 Jun;52(6):762-71. doi: 10.1165/rcmb.2014-0092OC.

PMID:
25353067
40.

Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS.

Papapetropoulos A, Hobbs AJ, Topouzis S.

Br J Pharmacol. 2015 Mar;172(6):1397-414. doi: 10.1111/bph.12980. Epub 2015 Jan 12. Review.

41.

Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.

Panza E, De Cicco P, Armogida C, Scognamiglio G, Gigantino V, Botti G, Germano D, Napolitano M, Papapetropoulos A, Bucci M, Cirino G, Ianaro A.

Pigment Cell Melanoma Res. 2015 Jan;28(1):61-72. doi: 10.1111/pcmr.12312. Epub 2014 Oct 6.

PMID:
25205294
42.

The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P.

Br J Pharmacol. 2015 Mar;172(6):1587-606. doi: 10.1111/bph.12811. Epub 2014 Sep 23. Review.

43.

Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners.

Papapetropoulos A, Whiteman M, Cirino G.

Br J Pharmacol. 2015 Mar;172(6):1633-7. doi: 10.1111/bph.12806. Epub 2014 Sep 5. Review.

44.

Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.

Gerö D, Szoleczky P, Chatzianastasiou A, Papapetropoulos A, Szabo C.

Mol Med. 2014 Jul 31;20:313-28. doi: 10.2119/molmed.2014.00102.

45.

Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.

Ghosh A, Stasch JP, Papapetropoulos A, Stuehr DJ.

J Biol Chem. 2014 May 30;289(22):15259-71. doi: 10.1074/jbc.M114.559393. Epub 2014 Apr 14.

46.

Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro.

Módis K, Coletta C, Asimakopoulou A, Szczesny B, Chao C, Papapetropoulos A, Hellmich MR, Szabo C.

Nitric Oxide. 2014 Sep 15;41:146-56. doi: 10.1016/j.niox.2014.03.001. Epub 2014 Mar 22.

47.

Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition.

Bucci M, Vellecco V, Cantalupo A, Brancaleone V, Zhou Z, Evangelista S, Calderone V, Papapetropoulos A, Cirino G.

Cardiovasc Res. 2014 Apr 1;102(1):138-47. doi: 10.1093/cvr/cvu026. Epub 2014 Feb 5.

PMID:
24501330
48.

Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics.

Rekowski MVW, Kumar V, Zhou Z, Moschner J, Marazioti A, Bantzi M, Spyroulias GA, van den Akker F, Giannis A, Papapetropoulos A.

J Med Chem. 2013 Nov 14;56(21):8948-8952. doi: 10.1021/jm400539d. Epub 2013 Oct 24.

49.

Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A.

Módis K, Panopoulos P, Coletta C, Papapetropoulos A, Szabo C.

Biochem Pharmacol. 2013 Nov 1;86(9):1311-9. doi: 10.1016/j.bcp.2013.08.064. Epub 2013 Sep 4.

PMID:
24012591
50.

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Módis K, Bos EM, Calzia E, van Goor H, Coletta C, Papapetropoulos A, Hellmich MR, Radermacher P, Bouillaud F, Szabo C.

Br J Pharmacol. 2014 Apr;171(8):2123-46. doi: 10.1111/bph.12368. Review.

Supplemental Content

Loading ...
Support Center